Why would the DEA decide to legalize THC only for pharmaceutical companies? Well, because Big Pharma requested it, of course! As the DEA says on the subject:
"The DEA has received four petitions from companies that have products that are currently the subject of ANDAs (abbreviated new drug applications) under review by the FDA. ...While the petitioners cite that their generic products are bioequivalent to Marinol, their products do not meet schedule III current definition provided above. Therefore, these firms have requested that 21 CFR 1308.13(g)(1) be expanded to include naturally derived or synthetically produced dronabinol."
You can read it all at the DEA's own website: http://www.deadiversion.usdoj.gov/f...
"The DEA has received four petitions from companies that have products that are currently the subject of ANDAs (abbreviated new drug applications) under review by the FDA. ...While the petitioners cite that their generic products are bioequivalent to Marinol, their products do not meet schedule III current definition provided above. Therefore, these firms have requested that 21 CFR 1308.13(g)(1) be expanded to include naturally derived or synthetically produced dronabinol."
You can read it all at the DEA's own website: http://www.deadiversion.usdoj.gov/f...
No comments:
Post a Comment